Personalized exposure assessment: Promising approaches for human environmental health research

Environmental Health Perspectives

Volumn 113, Issue 7, 2005, Pages 840-848

  Weis, Brenda K ^a   Balshaw, David ^a   Barr, John R ^b   Brown, David ^a   Ellisman, Mark ^c   Lioy, Paul ^d   Omenn, Gilbert ^e   Potter, John D ^f   Smith, Martyn T ^g   Sohn, Lydia ^h   Suk, William A ^a   Sumner, Susan ⁱ   Swenberg, James ^j   Walt, David R ^k   Watkins, Simon ^l   Thompson, Claudia ^a   Wilson, Samuel H ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RUTGERS UNIVERSITY   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ RTI INTERNATIONAL   (United States)

^j UNIVERSITY OF NORTH CAROLINA   (United States)

^k TUFTS UNIVERSITY   (United States)

^l UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Body burden; Epidemiology; Exposure; Exposure assessment; Exposure technology; Geographic information systems; GIS; Sensors

Indexed keywords

CHEMICAL COMPOUND;

ANALYTIC METHOD; BEHAVIOR; BIOSENSOR; BODY BURDEN; DIETARY INTAKE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ENVIRONMENTAL HEALTH; ENVIRONMENTAL IMPACT ASSESSMENT; ENVIRONMENTAL MONITORING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GEOGRAPHIC INFORMATION SYSTEM; HEALTH CARE ORGANIZATION; HEREDITY; HUMAN; INFECTION; LIFESTYLE; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; TOXICOGENETICS;

BIOLOGICAL MARKERS; BODY BURDEN; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; GEOGRAPHIC INFORMATION SYSTEMS; HUMANS; RESEARCH; TOXICOGENETICS; XENOBIOTICS;

EID: 22144456709     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.7651     Document Type: Review

References (121)

1. Balbatun A, Louka FR, Malinski T. 2003. Dynamics of nitric oxide release in the cardiovascular system. Acta Biochim Pol 50(1):61-68.
2. Ball C, Brazma A, Causton H, Chervitz S, Edgar R, Hingamp P, et al. 2004. Microarray data standards: an open letter [Letter]. Environ Health Perspect 112:A666-A667.
3. Bammler T, Beyer RP, Bhattacharya S, Boorman GA, Boyles A, Bradford BU, et al. 2005. Standardizing global gone expression analysis between laboratories and across platforms. Nat Methods 2:351-356.
4. Barr JR, Maggio VL, Barr DB, Turner WE, Sjodin A, Sandau CD, et al. 2003. New high-resolution mass spectrometric approach for the measurement of polychlorinated biphenyls and organochlorine pesticides in human serum. J Chromatog B 794(1):137-148.
5. Bayley H, Cremer PS. 2001. Stochastic sensors inspired by biology. Nature 413(688):226-230.
6. Bellander T, Berglind N, Gustavsson P, Jonson T, Nyberg F, Pershagen G, et al. 2001. Using geographic information systems to assess individual historical exposure to air pollution from traffic and house heating in Stockholm. Environ Health Perspect 109:633-639.
7. Beyea J, Hatch M. 1999. Geographic exposure modeling: a valuable extension of geographic information systems for use in environmental epidemiology. Environ Health Perspect 107(suppl 1):181-190.
8. Bocchetta M, Carbone M. 2004. Epidemiology and molecular pathology at crossroads to establish causation: molecular mechanisms of malignant transformation. Oncogene 23:6484-6491.
9. Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, Bethell HW, et al. 2002. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1h-NMR-based metabonomics. Nat Med 8(12):1439-1444.
10. Brown K. 2004. Up in the air. Science 305(5688):1228-1229.
11. Cao Y, Jin R, Mirkin CA. 2002. Nanoparticles with Raman spectroscopic fingerprints from DNA and RNA detection. Science 297:1536-1540.
12. Cao Y, Lee KYE, Kopelman R. 2004. Poly(decyl methacrylate)-based fluorescent pebble swarm nanosensors for measuring dissolved oxygen in biosamples. Analyst 129(8):745-750.
13. Center for Nanoscale Science and Technology. 2004. Nanotechnology in Homeland Security Workshop, 6-7 May, Urbana-Champaign, IL:University of Illinois. Available: http://www.cnst.uiuc.edu/Fora/NHSW/CNST-Nano%20for%20Homeland %20Security%20Workshop%20Program.pdf [accessed 1 March 2005].
14. Chen C, Yu M, Liaw Y, Wang L, Chiamprasert S, Martin F, et al. 1996. Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Am J Hum Genet 59:128-134.
15. Chevalier RL. 2004. Biomarkers of congenital obstructive neuropathy: past, present and future. J Urol 172(3):852-857.
16. Choi WWL, Lewis MM, Lawson D, Yin-Goen Q, Birdsong GG, Cotsonis GA, et al. 2004. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and the VEGF-family gene expression. Mod Pathol 18(1):143-152.
17. Chung CH, Bernard PS, Perou CM. 2002. Molecular portraits and the family tree of cancer. Nat Gen 32(suppl):533-540.
18. Coen M, Lenz EM, Nicholson JK, Wilson ID, Pognan F, Lindon JC. 2003. An integrated metabonomics investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chem Res Toxicol 16:295-303.
19. Collins F. 2004. The case for a US prospective cohort study of genes and environment. Nature 429:475-477.
20. Committee on Biological Markers of the NRC (National Research Council). 1987. Biological markers in environmental health research. Environ Health Perspect 74:3-9.
21. Cook DN, Wang S, Wang Y, Howles GP, Whitehead GS, Berman KG, et al. 2004. Genetic regulation of endotoxin-induced airway disease. Genomics 83:961-969.
22. Cui Y, Wei Q, Park H, Liebler CM. 2001. Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species. Science 293(5533):1289-1292.
23. Culha M, Stokes DL, Griffin GD, Vo-Dinh T. 2004. Application of a miniature biochip using the molecular beacon probe in breast cancer gene BRAC1 detection. Biosens Bioelectron 19(9):1007-1012.
24. Doll R, Peto R. 1981. The causes of cancer. J Nat Cancer Inst 66:1191-1308.
25. Environmental Genome Project. 2005. GeneSNPs Database. Available: http://www.genome.utah.edu/genesnps/ [accessed 1 March 2005].
26. Elgethun K, Fenske RA, Yost MG, Palcisko GJ. 2003. Time-location analysis for exposure assessment studies of children using a novel global positioning system instrument. Environ Health Perspect 111:115-215.
27. EMMMA. 2004. Environmental Mercury Mapping, Modeling and Analysis. Overview - What We Do. Available: http://emmma.usgs.gov/ [accessed 21 December 2004].
28. Fehr M, Okumoto S, Deuschle K, Lager I, Looger LL, Persson J, et al. 2005. Development and use of fluorescent nanosensors for metabolite imaging in living cells. Biochem Soc Trans 33(Pt 1):287-290.
29. Freeman K. 2004. Toxicogenomics data: the road to acceptance. Environ Health Perspect 112:A678-A685.
30. Gavaghan CL, Holmes E, Lenz E, Wilson ID, Nicholson JK. 2000. An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk:ApfCD mouse. FEBS Lett 484:169-174.
31. Georgieva T, Michailova A, Panev T, Popov T. 2002. Possibilities to control the health risk of petrochemical workers. Int Arch Occup Environ Health 75(suppl):S21-S26.
32. Georgopoulos PG, Purushothaman V, Chiou R. 1997. Comparative evaluation of methods for estimating potential exposure to ozone: photochemical modeling and ambient monitoring. J Exp Anal Environ Epidemiol 7:191-215.
33. German JB, Roberts M-A, Watkins SM. 2003. Genomics and metabolomics as markers for the interaction of diet and health: lessons from lipids. J Nutr 133(6 supl 1):2078S-2083S.
34. Gilliland FD, Gauderman WJ, Vora H, Rappaport E, Dubeau L. 2002a. Effects of glutathione-S-transferase M1, T1 and P1 on childhood lung function growth. Am J Respir Crit Care Med 166:710-716.
35. Gilliland FD, Li YF, Dubeau L, Berhane K, Avol E, McConnell R, et al. 2002b. Effects of glutathione-S-transferase, maternal smoking during pregnancy, and environmental tobacco smoke on asthma and wheezing in children. Am J Respir Crit Care Med 166:457-463.
36. Goldstein BD. 1995. the concept of biological markers in the field of risk assessment. Stem Cells 13(suppl 1):30-32.
37. Griffin JL, Walker LA, Shore RF, Nicholson JK. 2001. Metabolic profiling of chronic cadmium exposure in the rat. Chem Res Toxicol 14(10):1428-1434.
38. Hamadeh HK, Bushel PR, Jayadev S, Martin K, DiSorbo O, Sieber S, et al. 2002. Gene expression analysis reveals chemical-specific profiles. Toxicol Sci 67:219-231.
39. Haruyama T. 2003. Micro- and nanbiotechnology for biosensing cellular responses. Adv Drug Dis Rev 55(3):393-401.
40. Hellstrom L, Jarup L, Persson B, Axelson O. 2004. Using environmental concentrations of cadmium and lead to assess human exposure and dose. J Expo Anal Environ Epidemiol 14(5):416-423.
41. Hemminki K, Lonnstedt I, Vaittunen P, Lichtenstein P. 2001. Estimation of genetic and environmental components in colorectal and lung cancer and melanoma. Genet Epidemiol 20(1):107-116.
42. Henry CM. 2004. Standardizing DNA microarrays. Chem Eng News 82:36-39.
43. Holleman A, Cheok MH, don Boer ML, Yang W, Veerman AJ, Kazemie PD, et al. 2004. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med 351:533-542.
44. Holmes E, Nicholls AW, Lindon JC, Connor SC, Connelly JC, Haselden JN, et al. 2000. Chemometric models for toxicity classification based on NMR spectra of biofluids. Chem Res Toxicol 13:471-478.
45. Holmes E, Nicholson JK, Tranter G. 2001. Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks. Chem Res Toxicol 14:182-191.
46. Hood L, Heath JR, Phelps ME, Lin B. 2004. Systems biology technologies enable predictive and preventive medicine. Science 306(5696):640-643.
47. International HapMap Project. 2005. International HapMap Project Homepage. Available: http://hapmap.org [accessed 1 March 2005].
48. Jarup L. 2004. Health and environment information systems for exposure and disease mapping, and risk assessment. Environ Health Perspect 112:995-997.
49. Jianrong C, Yuqing M, Nongyue H, Xiaohua W, Sijiao L. 2004. Nanotechnology and biosensors. Biotechnol Adv 22(7):505-518.
50. Kaiser J. 2002. Proteomics: public-private group maps out initiatives. Science 296(5569):827.
51. Kalinowski L, Dobrucki IT, Malinski T. 2004. Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases. Circulation 109(2):2511-2517.
52. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, et al. 2002. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347(3):185-192.
53. Kimura J, Takada H, Nomura A, Ohno T, Mizuno Y, Saito M, et al. 2004. T1 and th2 cytokine production is suppressed at the level of transcriptional regulation in Kawasaki disease. Clin Exp Immunol 137(2):444-449.
54. Koo YE, Coo Y, Kopelman R, Koo SM, Brasuel M, Philbert MA. 2004. Real-time measurements of dissolved oxygen inside live cells by organically modified silicate fluorescent nanosensors. Anal Chem 76(9):2498-2505.
55. Künzli N, Jerrett M, Mack WJ, Beckerman B, LaBree L, Gilliland F, et al. 2005. Ambient air pollution and atherosclerosis in Los Angeles. Environ Health Perspect 113:201-206.
56. Lan Q, Zhang L, Li G, Vermeulen R, Weinberg RS, Dosemeci M, et al. 2004. Hematotoxicty in workers exposed to low levels of benzene. Science 306:1774-1776.
57. Lindon JC, Nicholson JK, Holmes E, Antti H, Bollard ME, Keun H, et al. 2003. Contemporary issues in toxicology: the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol Appl Pharmacol 187(3):137-146.
58. Lioy PJ. 1990. Assessing total human exposure to contaminants. Environ Sci Technol 24:938-945.
59. Lioy PJ. 1995. Measurement methods for human exposure analysis. Environ Health Perspect 103(suppl 3):35-43.
60. Liu G, Zhou W, Park S, Wang LI, Miller DP, Wain JC, et al. 2004. The SOD2 Val/Val genotype enhances the risk of non-small cell lung carcinoma by p53 and XRCC1 polymorphisms. Cancer 101(12):2802-2808.
61. Maier A, Savage RE, Haber LT. 2004. Assessing biomarker use in risk assessment - a survey of practitioners. J Toxicol Environ Health 67(8-10):687-695.
62. Marin A, Vidal JLM, Gonzalez EFJ, Frenich GA, Garrido FA, Glass CR, et al. 2004. Assessment of potential (inhalaton and dermal) and actual exposure to acetamiprid by greenhouse applicators using liquid chromatography-tandem mass spectrometry. J Chromatogr B 804(2):269-275.
63. Mehrvar M, Abdi M. 2004. Recent developments, characteristics, and potential applications of electrochemical biosensors. Anal Sci 20(8):1113-11126.
64. Merikangas KR. 2003. Implications of genomics for public health: the role of genetic epidemiology. Cold Spring Herb Symp Quant Biol 68:359-364.
65. Metcalf SW, Orloff KG. 2004. Biomarkers of exposure in community settings. J Toxicol Environ Health 67(8-10):715-726.
66. Meyers DA, Larj MJ, Lange L. 2004. Genetics of asthma and COPD. Similar results for different phenotypes. Chest 126(2 suppl):105S-110S.
67. Miljanic S, Knezevic Z, Stuhec M, Ranogajec-Komor M, Krpan K, Veki B. 2003. Energy dependence of new thermoluminescent detectors in terms of HP(10) values. Radiat Prot Dosimetry 106(3):253-256.
68. Miranda ML, Dolinoy DC. 2005. Using GIS-based approaches to support research on neurotoxicants and other children's environmental health threats. Neurotoxicology 26:223-228.
69. Mo J-W, Smart W. 2004. Lactate biosensors for continuous monitoring. Front Biosci 9:3384-3391.
70. Molidor R, Sturn A, Maurer M, Trajanoski Z. 2003. New trends in bioinformatics: from genome sequence to personalized medicine. Exp Gerontol 38(1):1031-1036.
71. Mooney LA, Madsen AM, Tang D, Orjuela MA, Tsai W-Y, Garduno ER, et al. 2005. Antioxidant vitamin supplementation reduces benzo(a)pyrene-DNA adducts and potential cancer risk in female smokers. Cancer Epidemiol Biomarkers Prev 14(1):237-242.
72. National Cancer Institute. 2004. Cancer Nanotechnology Plan: A Strategic Initiative to Transform Clinical Oncology and Basic Research Through the Directed Application of Nanotechnology. Bethesda, MD:National Cancer Institute, Available: http://nano.cancer.gov/alliance_cancer_nanotechnology_plan.pdf [accessed 21 December 2004].
73. NHANES. 2005. National Health and Nutrition Examination Survey. Atlanta, GA:Center for Disease Control and Prevention. Available: http://www.cdc.gov/nchs/nhanes.htm [accessed 1 March 2005].
74. NRC (National Research Coucil). 1991. Human Exposure Assessment for Airborne Pollutants: Advances and Opportunities. Washington, DC.:National Academy Press.
75. Nuckols JR, Ward MH, Jarup L. 2004. Using geographic information systems for exposure assessment in environmental epidemiology studies. Environ Health Perspect 112:1007-1015.
76. Omenn GS. 2002. The crucial role of public health sciences in the postgenomic era. Genet Med 4(6 suppl):21S-26S.
77. Omenn GS. 2004. The human proteome organization plasma proteome project pilot phase: reference specimens, technology platform comparisons, and standardized data submissions and analyses. Proteomics 4(5):1235-1240.
78. Orchard S, Taylor CF, Hermjakob H, Weimin-Zhu, Julian RK Jr, Apweiler R. 2004. Advances in the development of common interchange standards for proteomic data. Proteomics 4(8):2363-2365.
79. Pepe MS, Etzioni R, Feng Z, Potter JD, Thornquist MD, Winget M, et al. 2001. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93(14):1054-1061.
80. Perera FP, Mooney LA, Stampfer M, Phillips DH, Bell DA, Rundle A, et al. 2002. Associations between carcinogen-DNA damage, glutathione S-tranferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study. Carcinogenesis 23(10):1641-1646.
81. Perera FP, Tang D, Tu Y-H, Cruz LA, Borjas M, Whyatt RM. 2004. Biomarkers in maternal and newborn blood indicate heightened fetal susceptibility to procarcinogen DNA damage. Environ Health Perspect 112:1133-1136.
82. Perera FP, Weinstein IB. 1982. Molecular epidemiology and carcinogen-DNA-adduct detection: approaches to studies of human cancer causation. J Chron Dis 35:581-560.
83. Pesch B, Brunng T, Frentzel-Beyme R, Johnen G, Harth V, Hoffman VY, et al. 2004. Challenges to environmental toxicology and epidemiology: where we stand and which way to go? Toxicol Lett 151(1):255-266.
84. Petricoin EF, Ornstein DK, Liotta LA. 2004a. Clinical proteomics: applications for prostate cancer biomarker discovery and detection. Urol Oncol 22(4):322-324.
85. Petricoin EF, Rajapaske V, Herman EH, Arekani AM, Ross S, Knapton JD, et al. 2004b. Toxicoproteomics: serum proteomic pattern diagnostics for early detection of drug induced toxicities and cardioprotection. Toxicol Pathol 32(suppl 1):122-130.
86. Phelps TJ, Palumbo AV, Beliaev AS. 2002. Metabolomics and microarrays for improved understanding of phenotypic characteristics controlled by both genomics and environmental constraints. Curr Opin Biotech 13:20-24.
87. Phillips ML, Hall TA, Nurtan AE, Lynch R, Johnson DL. 2001. Use of positioning systems technology to track subject's location during environmental exposure sampling. J Expo Anal Environ Epidemiol 11(3):207-215.
88. Pirkle JL, Needham LL, Sexton K. 1995. Improving exposure assessment by monitorinng human tissues for toxic chemicals. Environ Health Perspect 103(suppl 3):45-48.
89. Poirier MC, Beland FA. 1992. DNA adduct measurements and tumor incidence during chronic carcinogen exposure in animal models: implications of DNA adduct-based human cancer risk assessment. Chem Res Toxicol 5:749-755.
90. Porod W, Werblin F, Chua LO, Roska T, Rodriguez-Vazquez A, Roska P, et al. 2004. Bio-inspired nano-sensor-enhanced CNN visual computer. Ann NY Acad Sci 1013:92-109.
91. Posadas EM, Davidson B, Kohn EC. 2004. Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature. Curr Opin Oncol 16(5):478-484.
92. Potter JD. 2004. Toward the last cohort. Cancer Epidemiol Biomarkers Prev 13(6):895-897.
93. Raamsdonk LM, Teusink B, Broadhurst D, Zhang N, Hayes A, Walsh M, et al. 2001. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat Biotechnol 19(1):45-50.
94. Rebbeck TR, Spitz M, Wu X. 2004. Assessing the function of genetic variants in candidate gene association studies. Nat Rev Genet 5:589-597.
95. Robertson DG, Reily MD, Sigler RE, Wells DF, Paterson DA, Braden TK. 2000. Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. Toxicol Sci 57:326-337.
96. Rollinson S, Allan JM, Law GR, Roddam PL, Smith MT, Skibola C, et al. 2004. High-throughput association testing on DNA pools to identify genetic variants that confer susceptibility to acute myeloid leukemia. Cancer Epidemiol Biomarkers Prev 13(5):795-800.
97. Rundle A, Tang D, Zhou J, Cho S, Perera FP. 2000. The association between glutathione S-transferase M1 genotype and polycyclic aromatic hydrocarbon-DNA adducts in breast tissue. Cancer Epidemiol Biomarkers Prev 9:1079-1085.
98. Salimi A, Compton RG, Hallaj R. 2004. Glucose biosensor prepared by glucose oxidase encapsulated sol-gel and carbon-nanotube-modified basal plane pyrolytic graphite electrode. Anal Biochem 333(1):49-56.
99. Schulte PA. 1989. A conceptual framework for the validation and use of biologic markers. Environ Res 48:129-144.
100. Schulte PA, Perera FP, eds. 1993. Validation. In: Molecular Epidemiology. San Diego, CA:Academic Press, 81-104.
101. Schwartz DA, Freedman JH, Linney EA. 2004. Environmental genomics: a key to understanding biology, pathophysiology and disease. Hum Mol Genet 13:R217-R224.
102. Sharma M, Batra J, Mabalirajan U, Goswami S, Ganguly D, Lahkar B, et al. 2004. Suggestive evidence of association of C-159T functional polymorphism of the CD14 gene with atopic asthma in northern and northwestern Indian populations. Immunogenetics 56:544-547.
103. Skibola CF, Forrest MS, Coppede F, Agana L, Hubbard A, Smith MT, et al. 2004. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkins lymphoma. Blood 104(7):2155-2162.
104. Spitz MR, Wu X, Mills G. 2005. Integrative epidemiology: from risk assessment to outcome prediction. J Clin Oncol 23(2):267-275.
105. Suarez-Merino B, Hubank M, Revesz T, Harkness W, Hayward R, Thompson D, et al. 2005. Microarray analysis of pediatric epindymoma identifies a cluster of 112 candidate genes including four transcription factors at 22q12.1-q13.3. Neuro-oncol 7(1):20-31.
106. Svitel J, Surugiu I, Dzgoev A, Ramanathan K, Danielsson B. 2001. Functionalized surfaces for optical biosensors: applications to in vitro pesticide residual analysis. J Mater Sci Mater Med 12(10/12):1075-1078.
107. Swenberg JA. 2004. Toxicological considerations in the application and interpretation of DNA adducts in epidemiologic studies. IARC Sci Publ 157:237-246.
108. Tallman MS, Lefebvre P, Baine RM, Shoji M, Cohen I, Green D, et al. 2004. Effects of all-trans retinoic acid chemotherapy on the molecular regulation of systemic blood coagulation and fibronolysis in patients with acute promyelocytic leukemia. J Thromb Haemost 2(8):1341-1350.
109. Tang DL, Rundle A, Warburton D, Santella RM, Tsai WY, Chiamprase S, et al. 1995. Associations between both genetic and environmental biomarkers and lung cancer: evidence of a greater risk in lung cancer in women smokers. Carcinogenesis 19(11):1949-1953.
110. Toraason M, Albertini R, Bayard S, Bigbee W, Blair A, Boffetta P, et al. 2004. Applying now biotechnologies to the study of occupational cancer - a workshop summary. Environ Health Perspect 112:413-416.
111. Troyer DA, Mubiru J, Leach RJ, Naylor SL. 2004. Promise and challenge: markers of prostate cancer detection, diagnosis and prognosis. Dis Markers 20(2):117-128.
112. U.S. EPA. 1989. Risk Assessment Guidance for Superfund (RAGS) Part A. Washington, DC:U.S. Environmental Protection Agency. Available: http://www.epa.gov/oswer/riskassessment/ragsa/index.htm [accessed 20 January 2005].
113. U.S. EPA. 2004. Toxics Release Inventory (TRI) Program. Washington, DC:U.S. Environmental Protection Agency. Available: http://www.epa.gov/tri/ [accessed 21 December 2004].
114. Veglia F, Matullo G, Vineis P. 2003. Bulky DNA adducts and risk of cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 12:157-160.
115. Vo-Dinh T. 2002. Nanobiosensors: probing the sanctuary of individual living cells. J Cell Biochem 39(suppl):154-161.
116. Waters MD, Fostel JM. 2004. Toxicogenomics and systems toxicology: aims and prospects. Nat Rev 5:936-948.
117. Whyatt RM, Santella RM, Jedrychowski W, Garte SJ, Bell DA, Ottman G-YA, et al. 1998. Relationship between ambient air pollution and DNA damage in Polish mothers and newborns. Enviorn Health Perspect 106(suppl 3):821-826.
118. Wilson SH, Suk WA. In press. Framework for environmental exposure research: the disease-first approach. Mol Intervent.
119. World Cancer Research Fund Panel. 1997. Food Nutrition and the Prevention of Cancer: A Global Perspective. Washington, DC:American Institute for Cancer Research.
120. www.biosensors-congress.elsovier.com. 2004. Eighth World Congress on Biosensors, 24-26 May, Granada, Spain. Available: http://www.biosensors-congress.elsevier.com/bios04/menu.htm [accessed 21 December 2004].
121. Yauk CL, Berndt ML, Williams A, Douglas GR. 2004. Comprehensive comparison of six microarray technologies. Nucl Acid Res 32(15):e124. Available: http://nar.oupjournals.org/cgi/content/full/32/15/e124 [accessed 28 April 2005].